Global Microbial Incubators Market is valued at approximately USD 331.59 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2024-2032.

This manuscript characterizes a mutated clone of RNA polymerase I in yeast, referred to as SuperPol, to understand the mechanisms of RNA polymerase I elongation and termination. The authors present ...

Based on interviews with Founders Advisory managing partner Nicola O’Rourke, independent consultant, formerly of Wellington’s Development Kitchen, Dale Bowie, Professor Alan Renwick of Lincoln ...

Hepatitis B has a long incubation period. HEPLISAV-B may not prevent hepatitis B infection in individuals who have an unrecognized hepatitis B infection at the time of vaccine administration.

Four leading pharma companies - AstraZeneca, Merck, Pfizer, and Teva – along with Amazon Web Services, Inc. (AWS) and the Israel Biotech Fund (IBF) have also launched AION labs, an incubator to ...

It’s cheap and healthy. It’s the world’s most-preferred land-based meat. Turns out, it’s a good climate trade-off too. The ...

Record HEPLISAV-B® first quarter net product revenue of $65 million, representing 36% year-over-year growth Top-line results in Part 1 of Phase 1/2 shingles vaccine ...

Paulig took part in a seed-financing round held by Melt&Marble, which uses precision fermentation to produce fats from yeast ... investments and act as an incubator of small acquisitions until ...